Cercar
21/06/2023
Late-Onset Beta-Propeller Protein-Associated Neurodegeneration: A Case Report
Collet-Vidiella, R, Olmedo-Saura, G, Ruiz-Barrio, I, Martinez-Viguera, A, Rodriguez-Santiago, B, Bernal, S, Kulisevsky, J, Pagonabarraga, J. Late-Onset Beta-Propeller Protein-Associated Neurodegeneration: A Case Report. Movement Disorders Clinical Practice. 2023; 10(8)DOI:10.1002/mdc3.13811. PMID:37635772. IF:2.600(Q2/5D).
16/06/2023
Essential tremor: are we just splitting hairs? Non-motor symptoms and essential tremor-plus
Gironell, A. Essential tremor: are we just splitting hairs? Non-motor symptoms and essential tremor-plus. REVISTA DE NEUROLOGIA. 2023; 76(12)DOI:10.33588/rn.7612.2023083. PMID:37303101. IF:0.800(Q4/9D).
01/06/2023
Structural and metabolic brain correlates of arithmetic word-problem solving in Huntington's disease
Horta-Barba A., Martinez-Horta S., Sampedro F., Pérez-Pérez J., Pagonabarraga J., Kulisevsky J.. Structural and metabolic brain correlates of arithmetic word-problem solving in Huntington's disease. JOURNAL OF NEUROSCIENCE RESEARCH. 2023; 101(6)DOI:10.1002/jnr.25174. PMID:36807154. IF:2.900(Q2/5D).
01/05/2023
A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease
Gamez, J, Calopa, M, Munoz, E, Ferre, A, Huertas, O, McAllister, K, Reig, N, Scart-Gres, C, Insa, R, Kulisevsky, J. A proof-of-concept study with SOM3355 (bevantolol hydrochloride) for reducing chorea in Huntington's disease. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2023; 89(5)DOI:10.1111/bcp.15635. PMID:36494329. IF:3.100(Q2/4D).